Lineage Cell Therapeutics amends employment agreements and adopts bonus plan

Lineage Cell Therapeutics, Inc.

New employment agreements set salaries: CEO $690k, GC $394.8k, SVP $366.8k; bonus targets 55%, 40%, 35% respectively.
Termination benefits enhanced: CEO receives 12 months salary + 100% bonus (18 months + 150% on change of control); others receive 9 months + pro-rata (12 months + 100% on change of control).
New Executive Performance Incentive Bonus Plan adopted; bonuses tied to financial, clinical, and operational goals determined by Compensation Committee.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.